Kirby Institute
Clinical trials sponsored by Kirby Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New push to bring hepatitis c treatment to drug clinics Results expected Dec 2026 (estimated)
- When to boost? new trial seeks best COVID-19 shot timing for vulnerable patients Results expected Dec 2026 (estimated)
- Could a diabetes drug curb ice addiction? new trial aims to find out Results expected Jan 2027 (estimated)
-
HIV switch study: which combo works best after First-Line failure?
Disease control CompletedThis study tested two different drug combinations for people with HIV whose first treatment stopped working. 558 participants received either standard second-line drugs plus a newer integrase inhibitor (raltegravir) or the standard second-line drugs alone. The main goal was to se…
Phase 4 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New study tests faster hepatitis c detection for drug users
Knowledge-focused CompletedThis study looked at two faster ways to test for hepatitis C in people who recently injected drugs and visit needle exchange programs. One method uses a fingerstick test with results in about an hour, and the other uses a dried blood spot sent to a lab. The goal was to see if the…
Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC